Proinsulin C-peptide and G protein-coupled receptor 146 (GPR146) – clinical investigation of the impact of their signalling network on molecular pathways involved in diabetes-induced complications
2022/45/N/NZ4/01206
Keywords
Descriptors
- NZ4_006: Endokrynologia
- NZ5_003: Patogeneza chorób człowieka
- NZ5_007: Leczenie chorób człowieka
Panel
NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
Voivodeship: łódzkie
Principal investigator (from the host institution)
Number of co-investigators in the project: 3
Call
PRELUDIUM 21 – announced on 2022-03-28
- Amount awarded
- 209 669 PLN
- Project start date
- 2023-02-17
- Project end date
- 2026-02-16
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Cholesin receptor signalling is active in cardiovascular system-associated adipose tissue and correlates with SGLT2i treatment in patients with diabetes
- Authors:
- Aleksandra Ryk, Anna Marcinkiewicz, Jędrzej Chrzanowski, Arkadiusz Michalak, Izabela Dróżdz, Jacek Burzyński, Michał Krejca, Wojciech Fendler
- Academic press:
- Cardiovascular Diabetology (year: 2024, volume: 23, pages: 46031), Publisher: Springer Nature
- Status:
- Published
- DOI:
- 10.1186/s12933-024-02322-y – link to the publication